Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
RHC 80267
Cat. No.:
0225LY-0944
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
RHC 80267 acts as a selective inhibitor of DAGL, demonstrating an IC50 of 4 μM in canine platelets.
Synonym:
U-57908; 83654-05-1; Rhc 80267; RHC80267; 1,6-Bis(cyclohexyloximinocarbonyl)hexane; U 57908; 1,6-Di(O-(carbamoyl)cyclohexanone oxime)hexane; 9VB68H5WIT; Cyclohexanone O-((6-((((cyclohexylideneamino)oxy)carbonyl)amino)hexyl)carbamoyl) oxime; Cyclohexylideneamino N-[6-({[(cyclohexylideneamino)oxy]carbonyl}amino)hexyl]carbamate; Cyclohexanone O-6-((cyclohexylideneaminooxy)carbonylamino)hexylcarbamoyl oxime; Rg 80267; O,O'-((Hexane-1,6-diylbis(azanediyl))bis(carbonyl))dicyclohexanone oxime; N-[6-[[(cyclohexylideneamino)oxy-oxomethyl]amino]hexyl]carbamic acid (cyclohexylideneamino) ester
CAS No.:
83654-05-1
Compound CID:
5063
Formula:
C20H34N4O4
Formula Weight:
394.51
Specification
Targets&IC50:
DAGL: 4 µM in canine platelets
Relative Density:
1.21 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
RHC 80267 can be used in enzyme research to explore the inhibition of diacylglycerol lipase and its effect on lipid signaling.
Library Information
Target:
COX; Acyltransferase; AChR; Phospholipase
Receptor:
Acyltransferase; COX; DAGL; mAChR; Phosphatidylcholine; Phospholipase
Pathways:
Immunology/Inflammation; Neuronal signaling; Metabolism
Plate Number:
AOCL-13
Plate Location:
b5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
25 mg/mL; 63.37 mM
